73P Association between homologous recombination repair mutations and response to pembrolizumab (pembro) plus olaparib (ola) in metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 Cohort A biomarker analysis

E. Yu, J. M. Piulats,G. Gravis,P. Fong, T. Todenhoefer, B. Laguerre,J. Arranz, S. Oudard,C. Massard, M. Stoeckle, L. T. Nordquist,J. Carles,M. Huang,Y. Li,P. Qiu, C. H. Poehlein, C. Schloss,J. De Bono

Annals of Oncology(2021)

引用 9|浏览6
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要